UniProt ID | AT1A3_HUMAN | |
---|---|---|
UniProt AC | P13637 | |
Protein Name | Sodium/potassium-transporting ATPase subunit alpha-3 | |
Gene Name | ATP1A3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1013 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
Protein Description | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients.. | |
Protein Sequence | MGDKKDDKDSPKKNKGKERRDLDDLKKEVAMTEHKMSVEEVCRKYNTDCVQGLTHSKAQEILARDGPNALTPPPTTPEWVKFCRQLFGGFSILLWIGAILCFLAYGIQAGTEDDPSGDNLYLGIVLAAVVIITGCFSYYQEAKSSKIMESFKNMVPQQALVIREGEKMQVNAEEVVVGDLVEIKGGDRVPADLRIISAHGCKVDNSSLTGESEPQTRSPDCTHDNPLETRNITFFSTNCVEGTARGVVVATGDRTVMGRIATLASGLEVGKTPIAIEIEHFIQLITGVAVFLGVSFFILSLILGYTWLEAVIFLIGIIVANVPEGLLATVTVCLTLTAKRMARKNCLVKNLEAVETLGSTSTICSDKTGTLTQNRMTVAHMWFDNQIHEADTTEDQSGTSFDKSSHTWVALSHIAGLCNRAVFKGGQDNIPVLKRDVAGDASESALLKCIELSSGSVKLMRERNKKVAEIPFNSTNKYQLSIHETEDPNDNRYLLVMKGAPERILDRCSTILLQGKEQPLDEEMKEAFQNAYLELGGLGERVLGFCHYYLPEEQFPKGFAFDCDDVNFTTDNLCFVGLMSMIDPPRAAVPDAVGKCRSAGIKVIMVTGDHPITAKAIAKGVGIISEGNETVEDIAARLNIPVSQVNPRDAKACVIHGTDLKDFTSEQIDEILQNHTEIVFARTSPQQKLIIVEGCQRQGAIVAVTGDGVNDSPALKKADIGVAMGIAGSDVSKQAADMILLDDNFASIVTGVEEGRLIFDNLKKSIAYTLTSNIPEITPFLLFIMANIPLPLGTITILCIDLGTDMVPAISLAYEAAESDIMKRQPRNPRTDKLVNERLISMAYGQIGMIQALGGFFSYFVILAENGFLPGNLVGIRLNWDDRTVNDLEDSYGQQWTYEQRKVVEFTCHTAFFVSIVVVQWADLIICKTRRNSVFQQGMKNKILIFGLFEETALAAFLSYCPGMDVALRMYPLKPSWWFCAFPYSFLIFVYDEIRKLILRRNPGGWVEKETYY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 (in isoform 3) | Phosphorylation | - | 74.14 | 25850435 | |
8 (in isoform 3) | Phosphorylation | - | 70.95 | 25850435 | |
9 (in isoform 3) | Phosphorylation | - | 76.73 | 25850435 | |
10 | Phosphorylation | DKKDDKDSPKKNKGK CCCCCCCCCCCCCCC | 44.34 | 28985074 | |
37 | Phosphorylation | AMTEHKMSVEEVCRK HHHHHCCCHHHHHHH | 31.05 | 25332170 | |
45 | Phosphorylation | VEEVCRKYNTDCVQG HHHHHHHHCCCCCCC | 12.16 | 27732954 | |
56 | Phosphorylation | CVQGLTHSKAQEILA CCCCCCHHHHHHHHH | 25.17 | 25332170 | |
57 | Ubiquitination | VQGLTHSKAQEILAR CCCCCHHHHHHHHHC | 46.62 | - | |
71 | Phosphorylation | RDGPNALTPPPTTPE CCCCCCCCCCCCCHH | 31.19 | - | |
139 | Phosphorylation | ITGCFSYYQEAKSSK HHHHCHHHHHHHHHH | 9.93 | - | |
144 | Phosphorylation | SYYQEAKSSKIMESF HHHHHHHHHHHHHHH | 43.86 | 28152594 | |
145 | Phosphorylation | YYQEAKSSKIMESFK HHHHHHHHHHHHHHH | 26.04 | 28152594 | |
146 | Ubiquitination | YQEAKSSKIMESFKN HHHHHHHHHHHHHHH | 53.84 | 21890473 | |
150 | Phosphorylation | KSSKIMESFKNMVPQ HHHHHHHHHHHCCCC | 24.92 | 28152594 | |
152 | Ubiquitination | SKIMESFKNMVPQQA HHHHHHHHHCCCCCE | 54.11 | 21890473 | |
152 | Ubiquitination | SKIMESFKNMVPQQA HHHHHHHHHCCCCCE | 54.11 | 21890473 | |
152 | Ubiquitination | SKIMESFKNMVPQQA HHHHHHHHHCCCCCE | 54.11 | 21890473 | |
197 | Phosphorylation | PADLRIISAHGCKVD CCCEEEEEECCCEEC | 16.31 | 29523821 | |
202 | Ubiquitination | IISAHGCKVDNSSLT EEEECCCEECCCCCC | 58.16 | - | |
206 | Phosphorylation | HGCKVDNSSLTGESE CCCEECCCCCCCCCC | 23.43 | 23401153 | |
207 | Phosphorylation | GCKVDNSSLTGESEP CCEECCCCCCCCCCC | 35.88 | 23927012 | |
209 | Phosphorylation | KVDNSSLTGESEPQT EECCCCCCCCCCCCC | 40.63 | 23927012 | |
212 | Phosphorylation | NSSLTGESEPQTRSP CCCCCCCCCCCCCCC | 56.79 | 23927012 | |
216 | Phosphorylation | TGESEPQTRSPDCTH CCCCCCCCCCCCCCC | 43.78 | 18510355 | |
218 | Phosphorylation | ESEPQTRSPDCTHDN CCCCCCCCCCCCCCC | 28.60 | 24076635 | |
222 | Phosphorylation | QTRSPDCTHDNPLET CCCCCCCCCCCCCCC | 39.38 | 24076635 | |
265 | Phosphorylation | GRIATLASGLEVGKT HHHHHHHHCCCCCCC | 47.20 | 21082442 | |
349 | Ubiquitination | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 21890473 | |
349 | Ubiquitination | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 21890473 | |
349 | Ubiquitination | ARKNCLVKNLEAVET HHCCCEECCHHHHHH | 42.75 | 21890473 | |
359 | Phosphorylation | EAVETLGSTSTICSD HHHHHHCCCCCCCCC | 23.46 | 28857561 | |
360 | Phosphorylation | AVETLGSTSTICSDK HHHHHCCCCCCCCCC | 28.26 | 28857561 | |
361 | Phosphorylation | VETLGSTSTICSDKT HHHHCCCCCCCCCCC | 19.92 | 28857561 | |
362 | Phosphorylation | ETLGSTSTICSDKTG HHHCCCCCCCCCCCC | 26.54 | 28857561 | |
365 | Phosphorylation | GSTSTICSDKTGTLT CCCCCCCCCCCCCCC | 37.99 | 28857561 | |
367 | Ubiquitination | TSTICSDKTGTLTQN CCCCCCCCCCCCCCC | 32.34 | 21890473 | |
368 | Phosphorylation | STICSDKTGTLTQNR CCCCCCCCCCCCCCC | 40.15 | 28857561 | |
370 | Phosphorylation | ICSDKTGTLTQNRMT CCCCCCCCCCCCCEE | 31.68 | 28857561 | |
372 | Phosphorylation | SDKTGTLTQNRMTVA CCCCCCCCCCCEEEE | 24.52 | 28857561 | |
434 | Ubiquitination | QDNIPVLKRDVAGDA CCCCCEECCCCCCCC | 46.95 | - | |
442 | Phosphorylation | RDVAGDASESALLKC CCCCCCCCHHHHHHH | 36.50 | 24076635 | |
444 | Phosphorylation | VAGDASESALLKCIE CCCCCCHHHHHHHHH | 23.01 | 25332170 | |
448 | Ubiquitination | ASESALLKCIELSSG CCHHHHHHHHHHCCC | 33.73 | - | |
458 | Ubiquitination | ELSSGSVKLMRERNK HHCCCCHHHHHHHCC | 37.96 | - | |
466 | Acetylation | LMRERNKKVAEIPFN HHHHHCCCEEECCCC | 50.67 | 7465817 | |
478 | Phosphorylation | PFNSTNKYQLSIHET CCCCCCCEEEEEEEC | 19.43 | 29083192 | |
481 | Phosphorylation | STNKYQLSIHETEDP CCCCEEEEEEECCCC | 13.33 | 29083192 | |
485 | Phosphorylation | YQLSIHETEDPNDNR EEEEEEECCCCCCCE | 31.37 | 29083192 | |
516 | Ubiquitination | STILLQGKEQPLDEE HHHHHCCCCCCCCHH | 39.97 | - | |
548 | Phosphorylation | RVLGFCHYYLPEEQF HHHHHHCEECCHHHC | 14.10 | 19605366 | |
549 | Phosphorylation | VLGFCHYYLPEEQFP HHHHHCEECCHHHCC | 7.66 | 25884760 | |
580 | Phosphorylation | LCFVGLMSMIDPPRA CEEEHHHHCCCCCHH | 20.03 | 18669648 | |
595 | Ubiquitination | AVPDAVGKCRSAGIK CCCCHHHHHHHCCCE | 21.63 | 21890473 | |
598 | Phosphorylation | DAVGKCRSAGIKVIM CHHHHHHHCCCEEEE | 40.07 | 20068231 | |
602 | Ubiquitination | KCRSAGIKVIMVTGD HHHHCCCEEEEEECC | 25.45 | 21890473 | |
607 | Phosphorylation | GIKVIMVTGDHPITA CCEEEEEECCCCCCH | 21.36 | 20068231 | |
613 | Phosphorylation | VTGDHPITAKAIAKG EECCCCCCHHHHHHC | 26.93 | 20068231 | |
615 | Ubiquitination | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 21890473 | |
615 | Ubiquitination | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 21890473 | |
615 | Ubiquitination | GDHPITAKAIAKGVG CCCCCCHHHHHHCCE | 31.51 | 21890473 | |
619 | Ubiquitination | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | 21890473 | |
619 | Ubiquitination | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | 21890473 | |
619 | Ubiquitination | ITAKAIAKGVGIISE CCHHHHHHCCEEEEC | 48.27 | 21890473 | |
625 | Phosphorylation | AKGVGIISEGNETVE HHCCEEEECCCCCHH | 37.21 | 25072903 | |
630 | Phosphorylation | IISEGNETVEDIAAR EEECCCCCHHHHHHH | 32.94 | 24076635 | |
643 | Phosphorylation | ARLNIPVSQVNPRDA HHCCCCHHHCCHHHC | 24.05 | 30266825 | |
656 | Phosphorylation | DAKACVIHGTDLKDF HCCEEEEECCCHHHC | 16.83 | 27251275 | |
665 | Phosphorylation | TDLKDFTSEQIDEIL CCHHHCCHHHHHHHH | 27.74 | - | |
688 | Ubiquitination | ARTSPQQKLIIVEGC EECCCCCEEEEEECC | 36.08 | 21890473 | |
688 | Ubiquitination | ARTSPQQKLIIVEGC EECCCCCEEEEEECC | 36.08 | 21890473 | |
688 | Ubiquitination | ARTSPQQKLIIVEGC EECCCCCEEEEEECC | 36.08 | 21890473 | |
695 | S-palmitoylation | KLIIVEGCQRQGAIV EEEEEECCCCCCCEE | 1.58 | 29575903 | |
705 | Phosphorylation | QGAIVAVTGDGVNDS CCCEEEEECCCCCCC | 21.59 | 24076635 | |
712 | Phosphorylation | TGDGVNDSPALKKAD ECCCCCCCHHHHHCC | 13.58 | 29255136 | |
716 | Ubiquitination | VNDSPALKKADIGVA CCCCHHHHHCCCEEE | 48.28 | 21890473 | |
717 | Ubiquitination | NDSPALKKADIGVAM CCCHHHHHCCCEEEC | 52.74 | 21890473 | |
729 | Phosphorylation | VAMGIAGSDVSKQAA EECCCCCCHHHHHHH | 26.30 | 22210691 | |
732 | Phosphorylation | GIAGSDVSKQAADMI CCCCCHHHHHHHCEE | 24.84 | 22210691 | |
763 | Ubiquitination | RLIFDNLKKSIAYTL EEEECCHHHHHHHHH | 51.21 | 21890473 | |
763 | Ubiquitination | RLIFDNLKKSIAYTL EEEECCHHHHHHHHH | 51.21 | 21890473 | |
763 | Ubiquitination | RLIFDNLKKSIAYTL EEEECCHHHHHHHHH | 51.21 | 21890473 | |
794 | Phosphorylation | NIPLPLGTITILCID CCCCCCCCEEEEEEE | 23.72 | - | |
819 | Phosphorylation | LAYEAAESDIMKRQP HHHHHHHHHHHHCCC | 27.92 | - | |
823 | Ubiquitination | AAESDIMKRQPRNPR HHHHHHHHCCCCCCC | 48.49 | - | |
833 | Ubiquitination | PRNPRTDKLVNERLI CCCCCCHHHHHHHHH | 54.44 | 21890473 | |
933 | Phosphorylation | ICKTRRNSVFQQGMK EECCCCCHHHHHHCC | 23.61 | 25954137 | |
940 | Ubiquitination | SVFQQGMKNKILIFG HHHHHHCCCCEEEEE | 63.01 | 2190698 | |
942 | Ubiquitination | FQQGMKNKILIFGLF HHHHCCCCEEEEECC | 33.11 | - | |
1011 | Phosphorylation | GGWVEKETYY----- CCCCEEECCC----- | 38.91 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
933 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AT1A3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AT1A3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VA0D1_HUMAN | ATP6V0D1 | physical | 26344197 | |
VATA_HUMAN | ATP6V1A | physical | 26344197 | |
TCPH_HUMAN | CCT7 | physical | 26344197 | |
VDAC1_HUMAN | VDAC1 | physical | 26344197 | |
VDAC2_HUMAN | VDAC2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00831 | Primary dystonia | |||||
OMIM Disease | ||||||
128235 | Dystonia 12 (DYT12) | |||||
614820 | Alternating hemiplegia of childhood 2 (AHC2) | |||||
601338 | Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) | |||||
Kegg Drug | ||||||
D00112 | G-Strophanthin (JAN); Ouabain; Ouabain octahydrate | |||||
D00297 | Digitoxin (JP16/USP/INN); Crystodigin (TN) | |||||
D00298 | Digoxin (JP16/USP); Lanoxicaps (TN); Lanoxin (TN) | |||||
D01240 | Deslanoside (JP16/USP/INN); Cedilanid-d (TN) | |||||
D01379 | Proscillaridin (JAN/USAN/INN); Talusin (TN) | |||||
D01972 | Lanatoside C (JP16/INN); Digilanogen C (TN) | |||||
D02587 | Metildigoxin (JP16); Lanirapid (TN) | |||||
D06881 | Acetyldigitoxin (INN); Acylanid (TN) | |||||
D07147 | Gitoformate (INN) | |||||
D07555 | Acetyldigoxin; Cedigossima (TN) | |||||
D07556 | beta-Acetyldigoxin; Acetyldigoxin beta isomer; Corotal (TN) | |||||
D09847 | Metildigoxin (INN); Medigoxin (BAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...